sanofi pasteur — The vaccines business of sanofi-aventis Group
Learn
VaccinePlace.com -- Search.  Know more.
Explore Protect Learn
Follow this link to www.daptacel.com    About Us  |  For Professionals  |  Tell a Friend

 
   
   
   
 
   
   
   
   
   
 
   
   
Is the DAPTACEL Vaccine Safe?

DAPTACEL vaccine has been demonstrated to be safe.7,8,10

• The rates of adverse reactions to DAPTACEL vaccine (n= 2587) were similar to the DT placebo-control vaccine (n=2574). 7,8

• A vaccine with mild side effects may help parents comply with immunization recommendations for their children.6,8

• There are risks associated with all vaccines. Local and systemic adverse reactions may include redness, swelling, pain or tenderness at the injection site, fever, irritability, prolonged crying, drowsiness, vomiting, and anorexia. Other local and systemic adverse reactions may occur.

Remember, immunizations are one of the most important ways parents can protect their children against diseases like pertussis. Before the pertussis vaccine was developed, over 260,000 cases of pertussis and 9000 deaths due to pertussis were reported each year in the United States.8,9 But thanks to vaccination, millions of children are protected from serious, life-threatening diseases like pertussis.

Get more information:

Protection Safety Packaging Prescribing Information

Reference:
6. American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood immunization schedule—United States, 2002. Pediatrics. 2002;109:162-164.
7. DAPTACEL Vaccine Prescribing Information, March 2003.
8. Gustafsson L, Hallander HO, Ohio P, et al. A controlled trial of two-component acellular, aa five component acellular, and a wholecell pertussis vaccine. N Engl J Med. 1966;334:349-355.
9. WHO meeting on case definition of pertussis: Geneva, 10-11 January 1991. Geneva, Switzerland: World Health Organization: 1991:4-5. issue MIM/EPI/PERT/91.1.
10. Decker MD, Edwards KM, Steinhoff MC, et al. Comparison of 13 acellular pertussis vaccines: adv erse reactions. Pediatrics. 1995; 96 (suppl):557-566.



 
This site provided as a service by sanofi pasteur
 
Indication
 
DAPTACEL vaccine is given to infants and children 6 weeks through 6 years of age (prior to 7th birthday) to prevent three serious diseases: diphtheria, tetanus (lockjaw), and pertussis (whooping cough) as a five-dose series.
 
Safety Information
 
Side effects to DAPTACEL vaccine include injection site redness, swelling, and tenderness; fever, fussiness, drowsiness, and crying more than usual. Other side effects may occur. DAPTACEL vaccine should not be given to children who, after a previous dose of the vaccine, have had a serious allergic reaction (anaphylactic reaction) or inflammation of the brain (encephalopathy) not attributable to another cause. Tell the doctor if your child has ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Vaccination with DAPTACEL vaccine may not protect all individuals.
 
For more information about DAPTACEL vaccine, talk to your health-care professional.
 

Last modified: 2/20/09
Provided as a service by Sanofi Pasteur Inc.
Copyright © 2010 Sanofi Pasteur Inc.
This page last updated: 11-Aug-2010